Abstract
We examined the effect of lacto-N-biose I (LNB) on Antigen (Ag)-specific responses of immune cells. LNB exposure in vitro suppressed Ag-specific Interleukin (IL)-4 secretion of mouse splenocytes significantly. However, IL-4 secretion from CD4+ T cells stimulated with anti-CD3ε did not changed significantly with LNB exposure. Additionally, Ag-specific Th1 cytokines did not change. Therefore LNB might suppress Ag-specific IL-4 through modification of Ag-presenting cells (APCs) in a manner independent of Th1-type immune development.
Keywords: LNB, IL-4, naïve immune cells, anti-allergy
Common structures in biologically functional sugar chains often interact with particular molecules causing various responses. Lacto-N-biose I (Galβ1-3GlcNAc, LNB) is one of such common structural units in glycoconjugates. LNB exists at the non-reducing end of the type I core structures of human milk oligosaccharides (HMOs) [1, 2]. Discovery of an LNB-specific metabolizing pathway in bifidobacteria has suggested that LNB behaves as a growth-promoting factor, explaining their rapid intestinal colonization in breast-fed infants [3,4,5]. Oral administration of LNB is expected to help the growth of bifidobacteria [6, 7], especially for bottle-fed infants. A practical enzymatic method has been developed to produce LNB as a food ingredient [8].
Recent studies suggested that some oligosaccharides modulate immune reactions directly [9,10,11,12]. Considering the utilization of LNB as a food material, such direct effect should be examined. The present study was conducted to investigate the immunomodulatory functions of LNB using naïve immune cells from DO11.10 mice, which express the T cell receptor (TCR) specific for Chiken ovalbumin (OVA). The DO11.10 mice were purchased from The Jackson Laboratory (Boston, MA, USA) and maintained in our specific pathogen-free animal facilities. The animal studies were reviewed and approved by the Animal Care and Use Committee of the National Food Research Institute, National Agriculture and Food Research Organization (NARO), Japan.
The medium used for cell culture was RPMI 1640 (Sigma-Aldrich, St. Louis, MO, USA) containing 2-mercaptoethanol (50 μM), penicillin (100 U/mL), streptomycin (100 μg/mL) and 10% fetal calf serum (Biowest, Nuaille, France). LNB [8] was dissolved in sterile PBS at a concentration of 2 mg/mL and was stored at –30°C as a stock solution. The LNB stock solution was diluted with culture medium immediately before use.
Single-cell suspensions of splenocytes were prepared from individual DO11.10 mice by mechanical dispersion and suspended at 1 × 106 cells/mL with culture medium in 96-well culture plates (Nunc, Boston, MA, USA). Splenocytes were treated with 12.5, 25, 50 or 100 μM of LNB, and 7.5 μM of intact OVA (fraction V grade, Sigma-Aldrich) for up to 72 hr.
An Ag-specific cytokine secretion assay was performed in a total volume of 300 μL per well. Culture supernatants were collected at 48 hr (for measurement of IL-2, IL-4 and IL-5) and at 72 hr (for measurement of IL-6, IL-12p40 and IFN-γ) after OVA stimulation. Supernatants were stored at –30°C until use. Cytokines were measured using Mouse Cytokine ELISA Ready-SET-Go! kits (eBioscience, San Diego, CA, USA). CD4+ T cells were prepared from pooled splenocytes from four DO11.10 mice by a MACS® system (Miltenyi Biotec, Bergisch Gladbach, Germany). CD4+ T cells (1 × 106 cells/mL) separated by anti-mouse CD4 labeled MACS MicroBeads were stimulated with anti-CD3ε mAb (145-2C11, eBioscience, San Diego, CA, USA) immobilized on plastic plate (0.5 μg/mL of anti-CD3ε in PBS was incubated for overnight at 4°C) for 48hr and 72 hr in the presence of LNB in a total volume of 300 μL per well. Culture supernatants were collected for measurement of IL-2, IL-4, IL-5, IL-6 and IFN-γ.
The effect of LNB exposure on secretion of Ag-specific Th1-type cytokines (IL-2, IL-12p40, and IFN-γ) and Th2-type cytokines (IL-4, IL-5 and IL-6) by splenocytes is shown in Figures 1 and 2. LNB exposure reduced Ag-specific IL-4 secretion significantly (Fig. 2A). IL-4 is the most important cytokine with respect to Ag-specific Th2 cell development. On the other hand, LNB did not change IL-4 secretion from splenic T cells stimulated with anti-CD3ε mAb (Fig. 3). Hence, LNB might suppress IL-4 secretion through modulation of antigen-presenting cell (APCs) functions.
Fig. 1.
The effect of LNB on antigen-specific Th1-type cytokine (A, IL-2; B, IL-12p40; C, IFN-γ) production by splenocytes from naïve mice.
Pooled splenocytes (3 × 105 cells/well) were cultured with 0 (control), 6.25, 25 or 100 μM of LNB in the presence of 7.5 μM of OVA in 96-well plates for 72 hr. Cytokine concentrations were measured using Mouse ELISA Ready-SET-Go! kits. The data shown are means ± SE from triplicate cultures. (Similar results were seen in three additional experiments with three to four mice.) Statistical comparisons were carried out using ANOVA with Dunnett’s multiple comparison of means test.
Fig. 2.
The effect of LNB on antigen-specific Th2-type cytokines (A, IL-4; B, IL-5; C, IL-6) production by splenocytes from naïve mice.
Pooled splenocytes (3 × 105 cells/well) were cultured with 0 (control), 6.25, 25 or 100 μM of LNB in the presence of 7.5 μM of OVA in 96-well plates for 72 hr. Cytokine concentrations were measured using Mouse ELISA Ready Set Go! kits. The data shown are means ± SE from triplicate cultures. (Similar results were seen in three additional experiments with three to four mice.) Statistical comparisons were carried out using ANOVA with Dunnett’s multiple comparison of means test; comparison with the control showed significant difference (*p≤0.05).
Fig. 3.
The effect of LNB on IL-4 production of splenic CD4+ T cells stimulated with anti-CD3ε antibody from naïve transgenic mice.
Splenic CD4+ T cells (1 × 105 cells/well) were cultured with 0 (control), 6.25, 25 or 100 μM of LNB stimulated with immobilized anti-CD3ε antibody in 96-well plates for 72 hr. IL-4 concentrations were measured using a Mouse ELISA Ready-SET-Go! kit. The data shown are means ± SE from triplicate cultures. (Similar results were seen in three additional experiments with three to four mice.) Statistical comparisons were carried out using ANOVA with Dunnett’s multiple comparison of means test.
LNB exposure did not change Ag-specific secretion of IL-12p40 and IFN-γ from splenocytes (Fig. 1B, C). IFN-γ is a representative Th1-type cytokine, and IL-12p40 is a subunit of bioactive IL-12 (IL-12p70), which is an essential inducer of Th1-type T cells that prevent Th2 immune cells development. We concluded that LNB exposure prevented IL-4 secretion without dependence on Th1-type cytokines.
Several oligosaccharides are recognized by pattern-recognition receptors (PRRs) including toll-like receptors (TLRs) and C-type lectin receptors [11, 12], which are expressed on APCs. Additionally, our results suggest that LNB exposure could not downregulate IL-4 secretion from T cells without signals from APCs. Therefore, LNB exposure might modify signals from APCs to T cells.
Galectins belong to lectins that have an affinity for β-galactosides and are secreted from the various cells to regulate immune cells homeostasis and inflammation [13,14,15]. Galectin-3 (Gal-3) is a chimera-type member of the galectin family and is associated with a proinflammatory role in fibrotic diseases [16, 17] and promotes macrophage activation [18, 19]. And some reports have indicated refreshing absence of Gal-3 leads to the development of a heightened Th1 response (IL-4 downregulation and IFN-γ upregulation) [20, 21]. Interestingly, exposure of lactose, which binds to Gal-3 disrupts association between TCR and Gal-3 and distorts the effects of Gal-3 [22], and it has been reported that LNB has affinity to Gal-3 similar to lactose [23]. Hence, we speculated that Gal-3 bound with LNB might cripple its regular functions partially and reduced Ag-specific IL-4 secretion only. In general, Gal-3 levels in lymphocytes are very low until induced by strong activating agents, and the expression of Gal-3 in T cells is low in comparison with other leukocytes [24]. Therefore, there might be a very small amount of a Gal-3 in the environment of purified T cell culture, and IL-4 secretion of CD4+ T cells stimulated with anti-CD3ε might not be affected by LNB exposure (Fig. 3).
Hence, we concluded that through modification of signals from APCs, LNB affects Ag-specific immune responses. To develop LNB as a food ingredient, pharmacological effects of LNB should be taken in account as well as the prebiotic effects.
Acknowledgments
We thank Michiko Yamamoto for technical assistance.
REFERENCES
- 1.Kobata A. 2010. Structures and application of oligosaccharides in human milk. Proc Jpn Acad, Ser B, Phys Biol Sci 86: 731–747 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Urashima T, Kitaoka M, Terabayashi T, Fukuda K, Ohnishi M, Kobata A. 2011. Milk oligosaccharides., In Oligosaccharides: sources, properties and applications, Nova Biochemical Books, New York, pp 1–58. [Google Scholar]
- 3.Kitaoka M, Tian J, Nishimoto M. 2005. Novel putative galactose operon involving lacto-N-biose phosphorylase in Bifidobacterium longum. Appl Environ Microbiol 71: 3158–3162 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Nishimoto M, Kitaoka M. 2007. Identification of N-acetylhexosamine 1-kinase in the complete lacto-N-biose I/galacto-N-biose metabolic pathway in Bifidobacterium longum. Appl Environ Microbiol 73: 6444–6449 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Fushinobu S. 2010. Unique sugar metabolic pathways of bifidobacteria. Biosci Biotechnol Biochem 74: 2374–2384 [DOI] [PubMed] [Google Scholar]
- 6.Kiyohara M, Tachizawa A, Nishimoto M, Kitaoka M, Ashida H, Yamamoto K. 2009. Prebiotic effect of lacto-N-biose I on bifidobacterial growth. Biosci Biotechnol Biochem 73: 1175–1179 [DOI] [PubMed] [Google Scholar]
- 7.Xiao JZ, Takahashi S, Nishimoto M, Odamaki T, Yaeshima T, Iwatsuki K, Kitaoka M. 2010. Distribution of in vitro fermentation ability of lacto-N-biose I, a major building block of human milk oligosaccharides, in bifidobacterial strains. Appl Environ Microbiol 76: 54–59 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Nishimoto M, Kitaoka M. 2007. Practical preparation of lacto-N-biose I, a candidate for the bifidus factor in human milk. Biosci Biotechnol Biochem 71: 2101–2104 [DOI] [PubMed] [Google Scholar]
- 9.Sonoyama K, Watanabe H, Watanabe J, Yamaguchi N, Yamashita A, Hashimoto H, Kishino E, Fujita K, Okada M, Mori S, Kitahata S, Kawabata J. 2005. Allergic airway eosinophilia is suppressed in ovalbumin-sensitized Brown Norway rats fed raffinose and alpha-linked galactooligosaccharide. J Nutr 135: 538–543 [DOI] [PubMed] [Google Scholar]
- 10.Pirapatdit S, Kishino E, Fujita K, Hashimoto H, Mori S, Saito S, Sato T, Watanabe J, Sonoyama K. 2008. Dietary alpha-linked galacto-oligosaccharide suppresses ovalbumin-induced allergic peritonitis in BALB/c mice. Biosci Biotechnol Biochem 72: 1901–1907 [DOI] [PubMed] [Google Scholar]
- 11.Wang Y, Da’Dara AA, Thomas PG, Harn DA. 2010. Dendritic cells activated by an anti-inflammatory agent induce CD4(+) T helper type 2 responses without impairing CD8(+) memory and effector cytotoxic T-lymphocyte responses. Immunology 129: 406–417 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Osanya A, Song EH, Metz K, Shimak RM, Boggiatto PM, Huffman E, Johnson C, Hostetter JM, Pohl NL, Petersen CA. 2011. Pathogen-derived oligosaccharides improve innate immune response to intracellular parasite infection. Am J Pathol 179: 1329–1337 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Rabinovich GA, Rubinstein N, Toscano MA. 2002. Role of galectins in inflammatory and immunomodulatory processes. Biochim Biophys Acta 1572: 274–284 [DOI] [PubMed] [Google Scholar]
- 14.Cerliani JP, Stowell SR, Mascanfroni ID, Arthur CM, Cummings RD, Rabinovich GA. 2011. Expanding the universe of cytokines and pattern recognition receptors: galectins and glycans in innate immunity. J Clin Immunol 31: 10–21 [DOI] [PubMed] [Google Scholar]
- 15.Zhuo Y, Bellis SL. 2011. Emerging role of alpha2,6-sialic acid as a negative regulator of galectin binding and function. J Biol Chem 286: 5935–5941 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Henderson NC, Mackinnon AC, Farnworth SL, Poirier F, Russo FP, Iredale JP, Haslett C, Simpson KJ, Sethi T. 2006. Galectin-3 regulates myofibroblast activation and hepatic fibrosis. Proc Natl Acad Sci USA 103: 5060–5065 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Nishi Y, Sano H, Kawashima T, Okada T, Kuroda T, Kikkawa K, Kawashima S, Tanabe M, Goto T, Matsuzawa Y, Matsumura R, Tomioka H, Liu FT, Shirai K. 2007. Role of galectin-3 in human pulmonary fibrosis. Allergol Int 56: 57–65 [DOI] [PubMed] [Google Scholar]
- 18.Sano H, Hsu DK, Yu L, Apgar JR, Kuwabara I, Yamanaka T, Hirashima M, Liu FT. 2000. Human galectin-3 is a novel chemoattractant for monocytes and macrophages. J Immunol 165: 2156–2164 [DOI] [PubMed] [Google Scholar]
- 19.MacKinnon AC, Farnworth SL, Hodkinson PS, Henderson NC, Atkinson KM, Leffler H, Nilsson UJ, Haslett C, Forbes SJ, Sethi T. 2008. Regulation of alternative macrophage activation by galectin-3. J Immunol 180: 2650–2658 [DOI] [PubMed] [Google Scholar]
- 20.Zuberi RI, Hsu DK, Kalayci O, Chen HY, Sheldon HK, Yu L, Apgar JR, Kawakami T, Lilly CM, Liu FT. 2004. Critical role for galectin-3 in airway inflammation and bronchial hyperresponsiveness in a murine model of asthma. Am J Pathol 165: 2045–2053 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Saegusa J, Hsu DK, Chen HY, Yu L, Fermin A, Fung MA, Liu FT. 2009. Galectin-3 is critical for the development of the allergic inflammatory response in a mouse model of atopic dermatitis. Am J Pathol 174: 922–931 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Demetriou M, Granovsky M, Quaggin S, Dennis JW. 2001. Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature 409: 733–739 [DOI] [PubMed] [Google Scholar]
- 23.Fort S, Kim HS, Hindsgaul O. 2006. Screening for galectin-3 inhibitors from synthetic lacto-N-biose libraries using microscale affinity chromatography coupled to mass spectrometry. J Org Chem 71: 7146–7154 [DOI] [PubMed] [Google Scholar]
- 24.Hsu DK, Chen HY, Liu FT. 2009. Galectin-3 regulates T-cell functions. Immunol Rev 230: 114–127 [DOI] [PubMed] [Google Scholar]



